Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgan Roupret

Showing results (121-130 of 273) with videos related to

Pageof 28
Sort By:
The Journal of Urology|August 15, 2015
Multiparametric Magnetic Resonance Imaging Predicts Postoperative Pathology but Misses Aggressive Prostate Cancers as Assessed by Cell Cycle Progression ScoreRaphaële Renard-Penna, Géraldine Cancel-Tassin, Eva Comperat, et al.
BJU International|May 24, 2021
Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registryFrancesco Soria, M Pilar Laguna, Morgan Roupret, et al.
The French Journal of Urology|December 14, 2025
Does radiotherapy after prostate enucleation with thulium fiber laser worsen functional outcomes: A mid-term retrospective analysis?Gatien Begel, Mickael Andraud, Louis Lenfant, et al.
European Urology Oncology|March 12, 2024
A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal DisparitiesOlivier Cussenot, Yoann Taille, Jean-Jacques Portal, et al.
Urologic Oncology|March 14, 2026
Refining prognostication in non-muscle-invasive bladder cancer: From clinical models to artificial intelligenceCéline Mardelli, Théophile Bertail, Isamu Tachibana, et al.
BJU International|December 2, 2008
Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experienceEvanguelos Xylinas, Sarah J Drouin, Eva Comperat, et al.
Seminars in Radiation Oncology|December 14, 2022
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder CancerBhanuPrasad Venkatesulu, Stanley L Liauw, Monika Joshi, et al.
European Journal of Radiology|November 24, 2020
Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350]Charlotte Christophe, Sarah Montagne, Stéphanie Bourrelier, et al.
BMC Cancer|September 3, 2016
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancerJean-Pierre Roperch, Bernard Grandchamp, François Desgrandchamps, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomyMehmet Özsoy, Marco Moschini, Harun Fajkovic, et al.
Pageof 28

Showing results (121-130 of 273) with videos related to

Sort By:
Pageof 28
The Journal of Urology|August 15, 2015
Multiparametric Magnetic Resonance Imaging Predicts Postoperative Pathology but Misses Aggressive Prostate Cancers as Assessed by Cell Cycle Progression ScoreRaphaële Renard-Penna, Géraldine Cancel-Tassin, Eva Comperat, et al.
BJU International|May 24, 2021
Flexible fibre optic vs digital ureteroscopy and enhanced vs unenhanced imaging for diagnosis and treatment of upper tract urothelial carcinoma (UTUC): results from the Clinical Research Office of the Endourology Society (CROES)-UTUC registryFrancesco Soria, M Pilar Laguna, Morgan Roupret, et al.
The French Journal of Urology|December 14, 2025
Does radiotherapy after prostate enucleation with thulium fiber laser worsen functional outcomes: A mid-term retrospective analysis?Gatien Begel, Mickael Andraud, Louis Lenfant, et al.
European Urology Oncology|March 12, 2024
A Comprehensive National Survey of Prostate-specific Antigen Testing and Prostate Cancer Management in France: Uncovering Regional and Temporal DisparitiesOlivier Cussenot, Yoann Taille, Jean-Jacques Portal, et al.
Urologic Oncology|March 14, 2026
Refining prognostication in non-muscle-invasive bladder cancer: From clinical models to artificial intelligenceCéline Mardelli, Théophile Bertail, Isamu Tachibana, et al.
BJU International|December 2, 2008
Oncological control after radical prostatectomy in men with clinical T3 prostate cancer: a single-centre experienceEvanguelos Xylinas, Sarah J Drouin, Eva Comperat, et al.
Seminars in Radiation Oncology|December 14, 2022
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder CancerBhanuPrasad Venkatesulu, Stanley L Liauw, Monika Joshi, et al.
European Journal of Radiology|November 24, 2020
Erratum to 'Prostate cancer local staging using biparametric MRI: Assessment and comparison with multiparametric MRI' [Eur. J. Radiol. 132 (2020) 109350]Charlotte Christophe, Sarah Montagne, Stéphanie Bourrelier, et al.
BMC Cancer|September 3, 2016
Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancerJean-Pierre Roperch, Bernard Grandchamp, François Desgrandchamps, et al.
Prostate Cancer and Prostatic Diseases|December 13, 2017
Elevated preoperative neutrophil-lymphocyte ratio predicts upgrading at radical prostatectomyMehmet Özsoy, Marco Moschini, Harun Fajkovic, et al.
Pageof 28